Discovery and validation of novel protein markers in mucosa of portal hypertensive gastropathy
Abstract Background Portal hypertension induced esophageal and gastric variceal bleeding is the main cause of death among patients of decompensated liver cirrhosis. Therefore, a standardized, biomarker-based test, to make an early-stage non-invasive risk assessment of portal hypertension, is highly...
Main Authors: | Ying Zhu, Wen Xu, Wei Hu, Fang Wang, Yan Zhou, Jianguo Xu, Wei Gong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-021-01787-5 |
Similar Items
-
Portal Hypertensive Gastropathy (Literature Review)
by: Yu.M. Stepanov, et al.
Published: (2016-04-01) -
Risk factors for portal hypertensive gastropathy
by: Ran Wu, et al.
Published: (2022-10-01) -
Accuracy of noninvasive tests in the prediction of portal hypertensive gastropathy in Egyptian patients with cirrhosis
by: Ibrahim F Amer, et al.
Published: (2021-02-01) -
Helicobacter pylori Infection in Patients with Portal Hypertensive Gastropathy Owing to Liver Cirrhosis: Prevalence and Relation with Severity of Gastropathy
by: Shekhar Puri, et al.
Published: (2017-07-01) -
Prevalence of Helicobacter pylori infection in patients with portal hypertensive gastropathy owing to liver cirrhosis in Upper Egypt
by: Khaled Abd-Alazeim Eid, et al.
Published: (2016-01-01)